Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Bacterial Infections and Mycoses

  Free Subscription


13.05.2024

1 Antimicrob Agents Chemother
1 BMC Neurol
1 BMC Pediatr
1 BMJ
2 Chest
8 Infect Immun
1 J Bacteriol
1 J Biol Chem
8 J Clin Microbiol
1 J Immunol
3 J Infect Dis
1 J Med Chem
1 J Med Microbiol
1 JAMA
2 MMWR Morb Mortal Wkly Rep
1 Neurology
2 Pediatrics
1 PLoS Biol
2 PLoS Comput Biol
5 PLoS Negl Trop Dis
16 PLoS One
5 PLoS Pathog


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. BERGIN S, Doorley LA, Rybak JM, Wolfe KH, et al
    Analysis of clinical Candida parapsilosis isolates reveals copy number variation in key fluconazole resistance genes.
    Antimicrob Agents Chemother. 2024 May 7:e0161923. doi: 10.1128/aac.01619.
    PubMed         Abstract available


    BMC Neurol

  2. AMIRIFARD H, Shahbazi M, Farahmand G, Ranjbar Z, et al
    Progressive multifocal leukoencephalopathy in a patient with B-cell chronic lymphocytic leukemia after COVID-19 vaccination, complicated with COVID-19 and mucormycosis: a case report.
    BMC Neurol. 2024;24:151.
    PubMed         Abstract available


    BMC Pediatr

  3. MUSE K, Urgessa K, Shume T, Tahir B, et al
    Prevalence, associated factors and antimicrobial susceptibility patterns of Salmonella and Shigella species among diarrheic under five children in Sultan Sheik Hassan Yabere referral Hospital, Jigjiga, Eastern Ethiopia.
    BMC Pediatr. 2024;24:311.
    PubMed         Abstract available


    BMJ

  4. KMIETOWICZ Z
    Whooping cough: Five infants die in England this year as cases continue to rise.
    BMJ. 2024;385:q1059.
    PubMed        


    Chest

  5. KU JH, Henkle E, Carlson KF, Marino M, et al
    Tolerability outcomes of ATS/IDSA guideline-recommended multi-drug antibiotic treatment for Mycobacterium avium complex pulmonary disease in U.S. Medicare beneficiaries with bronchiectasis.
    Chest. 2023 Dec 10:S0012-3692(23)05846-4. doi: 10.1016/j.chest.2023.
    PubMed         Abstract available

  6. ZWEIJPFENNING SMH, Aarnoutse R, Boeree MJ, Magis-Escurra C, et al
    Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial.
    Chest. 2024;165:1082-1092.
    PubMed         Abstract available


    Infect Immun

  7. LEWIS AJ, Richards AC, Mendez AA, Dhakal BK, et al
    Plant phenolics inhibit focal adhesion kinase and suppress host cell invasion by uropathogenic Escherichia coli.
    Infect Immun. 2024;92:e0008024.
    PubMed         Abstract available

  8. MELCHIOR K, Gerner RR, Hossain S, Nuccio S-P, et al
    IL-22-dependent responses and their role during Citrobacter rodentium infection.
    Infect Immun. 2024;92:e0009924.
    PubMed         Abstract available

  9. XING Y, Clark JR, Chang JD, Zulk JJ, et al
    Progress toward a vaccine for extraintestinal pathogenic E. coli (ExPEC) II: efficacy of a toxin-autotransporter dual antigen approach.
    Infect Immun. 2024 Apr 9:e0044023. doi: 10.1128/iai.00440.
    PubMed         Abstract available

  10. LANDWEHR KR, Granland CM, Martinovich KM, Scott NM, et al
    An infant mouse model of influenza-driven nontypeable Haemophilus influenzae colonization and acute otitis media suitable for preclinical testing of novel therapies.
    Infect Immun. 2024;92:e0045323.
    PubMed         Abstract available

  11. LOVELACE-MACON L, Baker SM, Ducken D, Seal S, et al
    Flagellin-modulated inflammasome pathways characterize the human alveolar macrophage response to Burkholderia pseudomallei, a lung-tropic pathogen.
    Infect Immun. 2024;92:e0006024.
    PubMed         Abstract available

  12. HART MT, Rom JS, Le Breton Y, Hause LL, et al
    The Streptococcus pyogenes stand-alone regulator RofA exhibits characteristics of a PRD-containing virulence regulator.
    Infect Immun. 2024 May 7:e0008324. doi: 10.1128/iai.00083.
    PubMed         Abstract available

  13. NISHIOKA ST, Snipper J, Lee J, Schapiro J, et al
    Group A Streptococcus induces lysosomal dysfunction in THP-1 macrophages.
    Infect Immun. 2024 May 9:e0014124. doi: 10.1128/iai.00141.
    PubMed         Abstract available

  14. YANG B, Vaisvil B, Schmitt D, Collins J, et al
    A correlative study of the genomic underpinning of virulence traits and drug tolerance of Candida auris.
    Infect Immun. 2024 May 9:e0010324. doi: 10.1128/iai.00103.
    PubMed         Abstract available


    J Bacteriol

  15. LEI MG, Jorgenson MA, Robbs EJ, Black IM, et al
    Characterization of Ssc, an N-acetylgalactosamine-containing Staphylococcus aureus surface polysaccharide.
    J Bacteriol. 2024 May 7:e0004824. doi: 10.1128/jb.00048.
    PubMed         Abstract available


    J Biol Chem

  16. MOTT PD, Zea AH, Lewis J, Mirzalieva O, et al
    Serine deamination by human serine racemase synergizes with antibiotics to curtail the replication of Chlamydia trachomatis.
    J Biol Chem. 2024 May 6:107350. doi: 10.1016/j.jbc.2024.107350.
    PubMed         Abstract available


    J Clin Microbiol

  17. BOGAERTS B, Van den Bossche A, Verhaegen B, Delbrassinne L, et al
    Closing the gap: Oxford Nanopore Technologies R10 sequencing allows comparable results to Illumina sequencing for SNP-based outbreak investigation of bacterial pathogens.
    J Clin Microbiol. 2024;62:e0157623.
    PubMed         Abstract available

  18. MOSTAFA HH
    An evolution of Nanopore next-generation sequencing technology: implications for medical microbiology and public health.
    J Clin Microbiol. 2024;62:e0024624.
    PubMed         Abstract available

  19. JACOT D, Gizha S, Orny C, Fernandes M, et al
    Development and evaluation of an artificial intelligence for bacterial growth monitoring in clinical bacteriology.
    J Clin Microbiol. 2024;62:e0165123.
    PubMed         Abstract available

  20. LANDRY ML, Hassan S, Rottmann BG, Pesak SJ, et al
    Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease.
    J Clin Microbiol. 2024;62:e0013924.
    PubMed         Abstract available

  21. OSBORN LJ, Fissel J, Gomez S, Mestas J, et al
    Development of an automated amplicon-based next-generation sequencing pipeline for rapid detection of bacteria and fungi directly from clinical specimens.
    J Clin Microbiol. 2024;62:e0174923.
    PubMed         Abstract available

  22. HAMILTON-SETH R, Streva V, Gammel N, Campodonico VL, et al
    Evaluation of false-positive Rhodotorula detections by a multiplex PCR-based fungal panel performed on positive blood culture bottles.
    J Clin Microbiol. 2024;62:e0017924.
    PubMed        

  23. FISHER J, Garrett EM
    The Brief Case: Cardiobacterium hominis endocarditis in a pediatric patient with congenital heart disease.
    J Clin Microbiol. 2024;62:e0156523.
    PubMed        

  24. ATTAWAY CC, Tobin E, Rhoads DD
    Photo Quiz: Unusual phenotypic and Lancefield group testing in blood culture isolate.
    J Clin Microbiol. 2024;62:e0118723.
    PubMed        


    J Immunol

  25. QING F, Sui L, He W, Chen Y, et al
    IRF7 Exacerbates Candida albicans Infection by Compromising CD209-Mediated Phagocytosis and Autophagy-Mediated Killing in Macrophages.
    J Immunol. 2024 May 6:ji2300826. doi: 10.4049/jimmunol.2300826.
    PubMed         Abstract available


    J Infect Dis

  26. LI M, Yang J, Zhou L, Zhang J, et al
    Efficacy of a novel affitoxin targeting MOMP against Chlamydia trachomatis in vitro and in vivo.
    J Infect Dis. 2024 May 9:jiae257. doi: 10.1093.
    PubMed         Abstract available

  27. PETRILLO S, Di Prinzio RR, Quatrana A, Santoro A, et al
    Redox biomarkers in asymptomatic latent human tuberculosis: a comparison with active disease.
    J Infect Dis. 2024 May 9:jiae254. doi: 10.1093.
    PubMed         Abstract available

  28. NICHOLSON LK, Kofonow JM, Robertson CE, Wright T, et al
    Clinical and Microbial Determinants of Upper Respiratory Colonization with Streptococcus pneumoniae and Native Microbiota in People with HIV-1 and Control Adults.
    J Infect Dis. 2024 May 8:jiae247. doi: 10.1093.
    PubMed         Abstract available


    J Med Chem

  29. HE Y, Ruan S, Liang G, Hao J, et al
    A Nonbactericidal Anionic Antimicrobial Peptide Provides Prophylactic and Therapeutic Efficacies against Bacterial Infections in Mice by Immunomodulatory-Antithrombotic Duality.
    J Med Chem. 2024;67:7487-7503.
    PubMed         Abstract available


    J Med Microbiol

  30. NG HK, Chua KH, Kee BP, Chuah KH, et al
    Genetic variations of penicillin-binding protein 1A: insights into the current status of amoxicillin-based regimens for Helicobacter pylori eradication in Malaysia.
    J Med Microbiol. 2024;73.
    PubMed         Abstract available


    JAMA

  31. HARRIS E
    Five-in-One Meningitis Vaccine Rolls Out.
    JAMA. 2024 May 10. doi: 10.1001/jama.2024.7727.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  32. OSBORN B, Hatfield J, Lanier W, Wagner J, et al
    Shiga Toxin-Producing Escherichia coli O157:H7 Illness Outbreak Associated with Untreated, Pressurized, Municipal Irrigation Water - Utah, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:411-416.
    PubMed         Abstract available

  33. NGUYEN MH, Hasan NA, De Moura VCN, Epperson LE, et al
    Notes from the Field: Potential Outbreak of Extrapulmonary Mycobacterium abscessus subspecies massiliense Infections from Stem Cell Treatment Clinics in Mexico - Arizona and Colorado, 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:420-422.
    PubMed         Abstract available


    Neurology

  34. GU Z, Guo K, Liu B, Hong Z, et al
    Area Postrema Syndrome as the Initial Presentation of CNS Tuberculosis.
    Neurology. 2024;102:e209443.
    PubMed        


    Pediatrics

  35. KLERK DH, van Varsseveld OC, Offringa M, Modi N, et al
    Core Outcome Set for Necrotizing Enterocolitis Treatment Trials.
    Pediatrics. 2024 May 10:e2023065619. doi: 10.1542/peds.2023-065619.
    PubMed         Abstract available

  36. MOLLOY MJ, Morris C, Caldwell A, LaChance D, et al
    Increasing the Use of Enteral Antibiotics in Hospitalized Children With Uncomplicated Infections.
    Pediatrics. 2024;153:e2023062427.
    PubMed         Abstract available


    PLoS Biol

  37. MAURE A, Lawaree E, Fiorentino F, Pawlik A, et al
    A host-directed oxadiazole compound potentiates antituberculosis treatment via zinc poisoning in human macrophages and in a mouse model of infection.
    PLoS Biol. 2024;22:e3002259.
    PubMed         Abstract available


    PLoS Comput Biol

  38. WHEELER J, Rosengart A, Jiang Z, Tan K, et al
    Informing policy via dynamic models: Cholera in Haiti.
    PLoS Comput Biol. 2024;20:e1012032.
    PubMed         Abstract available

  39. CHALLEN R, Chatzilena A, Qian G, Oben G, et al
    Combined multiplex panel test results are a poor estimate of disease prevalence without adjustment for test error.
    PLoS Comput Biol. 2024;20:e1012062.
    PubMed         Abstract available


    PLoS Negl Trop Dis

  40. DOUCHET L, Menkes C, Herbreteau V, Larrieu J, et al
    Climate-driven models of leptospirosis dynamics in tropical islands from three oceanic basins.
    PLoS Negl Trop Dis. 2024;18:e0011717.
    PubMed         Abstract available

  41. TUWOR RD, Mtuy TB, Amoako YA, Owusu L, et al
    Stigma experiences, effects and coping among individuals affected by Buruli ulcer and yaws in Ghana.
    PLoS Negl Trop Dis. 2024;18:e0012093.
    PubMed         Abstract available

  42. SEMA BALTAZAR C, Langa JP, Baloi LD, Elias Chitio JJ, et al
    Cholera and diarrheal diseases in Cuamba District, Niassa Province, Mozambique: Systematic healthcare facility-based surveillance strengthening, characteristics of suspected cholera and diarrheal patients, and incidence of diarrheal diseases.
    PLoS Negl Trop Dis. 2024;18:e0011843.
    PubMed         Abstract available


  43. Expression of Concern: Cell-Associated Flagella Enhance the Protection Conferred by Mucosally-Administered Attenuated Salmonella Paratyphi A Vaccines.
    PLoS Negl Trop Dis. 2024;18:e0012160.
    PubMed        

  44. SHOLEH M, Moradkasani S, Esmaeili S
    Epidemiology of tularemia in the countries of the WHO Eastern Mediterranean Region (EMRO): A systematic review and meta-analysis.
    PLoS Negl Trop Dis. 2024;18:e0012141.
    PubMed         Abstract available


    PLoS One

  45. CHAND AB, Basnet A, Maharjan B, Rai G, et al
    Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.
    PLoS One. 2024;19:e0301210.
    PubMed         Abstract available

  46. PHILO SE, Zhou NA, Lillis LM, Raghava V, et al
    Development, confirmation, and application of a seeded Escherichia coli process control organism to validate Salmonella enterica serovar Typhi environmental surveillance methods.
    PLoS One. 2024;19:e0301624.
    PubMed         Abstract available

  47. WHELAN AO, Flick-Smith HC, Walker NJ, Abraham A, et al
    A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model.
    PLoS One. 2024;19:e0294998.
    PubMed         Abstract available

  48. AMARE A, Asnakew F, Asressie Y, Guadie E, et al
    Prevalence of multidrug resistance Salmonella species isolated from clinical specimens at University of Gondar comprehensive specialized hospital Northwest Ethiopia: A retrospective study.
    PLoS One. 2024;19:e0301697.
    PubMed         Abstract available


  49. Retraction: Enhanced Immune Response and Protective Effects of Nano-chitosan-based DNA Vaccine Encoding T Cell Epitopes of Esat-6 and FL against Mycobacterium Tuberculosis Infection.
    PLoS One. 2024;19:e0303549.
    PubMed        

  50. ABDULLAHI AD, Unban K, Saenjum C, Kodchasee P, et al
    Antibacterial activities of Miang extracts against selected pathogens and the potential of the tannin-free extracts in the growth inhibition of Streptococcus mutans.
    PLoS One. 2024;19:e0302717.
    PubMed         Abstract available

  51. STATTIN K, Eriksson M, Frithiof R, Kawati R, et al
    Smoking is associated with higher risk of contracting bacterial infection and pneumonia, intensive care unit admission and death.
    PLoS One. 2024;19:e0302505.
    PubMed         Abstract available

  52. LV J, Geng L, Ye W, Gong S, et al
    Antimicrobial resistance and genetic relatedness of Salmonella serotypes isolated from food, asymptomatic carriers, and clinical cases in Shiyan, China.
    PLoS One. 2024;19:e0301388.
    PubMed         Abstract available

  53. SAVAGE JDT, Moore CM
    How do host population dynamics impact Lyme disease risk dynamics in theoretical models?
    PLoS One. 2024;19:e0302874.
    PubMed         Abstract available

  54. OROZCO-UGARRIZA ME, Olivo-Martinez Y, Rodger-Cervantes YE
    Protocol for the systematic review of the Pneumocystis jirovecii-associated pneumonia in non-HIV immunocompromised patients.
    PLoS One. 2024;19:e0302055.
    PubMed         Abstract available

  55. BURUSIE A, Enquesilassie F, Salazar-Austin N, Addissie A, et al
    Determinants of tuberculosis disease development in children in central Ethiopia: A matched case-control study.
    PLoS One. 2024;19:e0300731.
    PubMed         Abstract available

  56. CHOI Y, Kim IK, Kim SJ, Kim HS, et al
    Predictors of positive tuberculin skin test in neonates exposed to pulmonary tuberculosis.
    PLoS One. 2024;19:e0303050.
    PubMed         Abstract available

  57. LIU CW, Wu LS, Lin CJ, Wu HC, et al
    Association of tuberculosis risk with genetic polymorphisms of the immune checkpoint genes PDCD1, CTLA-4, and TIM3.
    PLoS One. 2024;19:e0303431.
    PubMed         Abstract available

  58. ZULU EM, Herlihy JM, Duffy CR, Mwananyanda L, et al
    Single-test syphilis serology: A case of not seeing the forest for the trees.
    PLoS One. 2024;19:e0303253.
    PubMed         Abstract available

  59. ALFADIL A, Ibrahem KA, Alrabia MW, Mokhtar JA, et al
    The fungicidal effectiveness of 2-Chloro-3-hydrazinylquinoxaline, a newly developed quinoxaline derivative, against Candida species.
    PLoS One. 2024;19:e0303373.
    PubMed         Abstract available

  60. BREEN P, Zimbric M, Caverly LJ
    Itaconic acid inhibits nontuberculous mycobacterial growth in pH dependent manner while 4-octyl-itaconic acid enhances THP-1 clearance of nontuberculous mycobacteria in vitro.
    PLoS One. 2024;19:e0303516.
    PubMed         Abstract available


    PLoS Pathog

  61. VANKAYALAPATI A, Durojaye O, Mukherjee T, Paidipally P, et al
    Metabolic changes enhance necroptosis of type 2 diabetes mellitus mice infected with Mycobacterium tuberculosis.
    PLoS Pathog. 2024;20:e1012148.
    PubMed         Abstract available

  62. ZANG X, Zhang J, Jiang Y, Feng T, et al
    Serine protease Rv2569c facilitates transmission of Mycobacterium tuberculosis via disrupting the epithelial barrier by cleaving E-cadherin.
    PLoS Pathog. 2024;20:e1012214.
    PubMed         Abstract available

  63. LOKKEN-TOYLI KL, Aggarwal SD, Bee GCW, de Steenhuijsen Piters WAA, et al
    Impaired upper respiratory tract barrier function during postnatal development predisposes to invasive pneumococcal disease.
    PLoS Pathog. 2024;20:e1012111.
    PubMed         Abstract available

  64. BAI Y, Xie C, Zhang Y, Zhang Z, et al
    sRNA expression profile of KPC-2-producing carbapenem-resistant Klebsiella pneumoniae: Functional role of sRNA51.
    PLoS Pathog. 2024;20:e1012187.
    PubMed         Abstract available

  65. DADELAHI AS, Abushahba MFN, Ponzilacqua-Silva B, Chambers CA, et al
    Interactions between B cells and T follicular regulatory cells enhance susceptibility to Brucella infection independent of the anti-Brucella humoral response.
    PLoS Pathog. 2023;19:e1011672.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.